Loading clinical trials...
Loading clinical trials...
An international, multicenter, epidemiological observational study aims to investigate the prevalence of genetic etiologies in patients diagnosed with FTD or clinically suspected for FTD.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
CENTOGENE GmbH Rostock
NCT07545473 · Dementia, Neurodegenerative Diseases, and more
NCT07531732 · Frontotemporal Dementia, Behavioral Variant, Alzheimer Disease
NCT03233646 · Alzheimer's Disease, Mild Cognitive Impairment, and more
NCT03489278 · Amyotrophic Lateral Sclerosis, ALS-Frontotemporal Dementia, and more
NCT05326750 · Alzheimer Disease, Frontotemporal Dementia, and more
AZ Damiaan
Ostend, West Flanders
CHU de Liege
Liège
Hanau Hospital
Hanau, Hesse
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions